Breast cancer staging should include breast MRI, study suggests

May 3, 2010

Breast magnetic resonance imaging (MRI) can detect breast lesions missed on mammography and ultrasound and help surgeons plan the most appropriate surgical treatment, improving patient outcomes, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.

Breast MRI offers valuable information about many breast conditions that cannot be obtained by other imaging modalities, such as mammography or . As a result, it is increasingly being used for the preoperative evaluation of patients with newly diagnosed breast cancer.

The study, performed at the University of Rome "La Sapienza" in Rome, Italy, included 164 women with biopsy-proven breast cancer. Researchers analyzed how breast MRI influenced the surgical management choices of those patients.

"Breast MRI changed the therapeutic procedure previously proposed based on conventional imaging (mammography and ultrasound) for 32/164 patients," said Valeria Dominelli, MD, lead author of the study. "Breast MRI also detected 51 additional suspicious lesions not seen on or ultrasound," said Dominelli.

"Breast MRI positively impacts patient management decisions and should be recommended for mapping tumor extent in patients with newly diagnosed . The correct assessment of the disease can help the surgeon plan the most appropriate surgical treatment, possibly reducing the need for re-intervention," she said.

Related Stories

Recommended for you

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

Liquid biopsy results differed substantially between two providers

December 14, 2017
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.